Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Mar 23;61(21):e202200377. doi: 10.1002/anie.202200377

Widely Distributed Bifunctional Bacterial Cytochrome P450 Enzymes Catalyze both Intramolecular C−C Bond Formation in cyclol‐Tyr‐l‐Tyr and Its Coupling with Nucleobases

Jing Liu 1,+, Lauritz Harken 1,+, Yiling Yang 1, Xiulan Xie 2, Shu‐Ming Li 1,
PMCID: PMC9401060  PMID: 35201649

Abstract

Tailoring enzymes are important modification biocatalysts in natural product biosynthesis. We report herein six orthologous two‐gene clusters for mycocyclosin and guatyromycine biosynthesis. Expression of the cyclodipeptide synthase genes gymA1 gymA6 in Escherichia coli resulted in the formation of cyclol‐Tyr‐l‐Tyr as the major product. Reconstruction of the biosynthetic pathways in Streptomyces albus and biochemical investigation proved that the cytochrome P450 enzymes GymB1–GymB6 act as both intramolecular oxidases and intermolecular nucleobase transferases. They catalyze not only the oxidative C−C coupling within cyclol‐Tyr‐l‐Tyr, leading to mycocyclosin, but also its connection with guanine and hypoxanthine, and are thus responsible for the formation of tyrosine‐containing guatyromycines, instead of the reported tryptophan‐nucleobase adducts. Phylogenetic data suggest the presence of at least 47 GymB orthologues, indicating the occurrence of a widely distributed enzyme class.

Keywords: Biosynthesis, Cyclodipeptide Synthase, Cytochrome P450 Enzymes, Natural Products, Nucleobase Transferase


Bioinformatic analysis unveiled a widely distributed two‐gene locus (gym) in actinobacteria. Reconstruction of the biosynthetic pathways and biochemical investigation led to the characterization of the cytochrome P450s GymBs as dual‐functional oxidases, which catalyze both intra‐ and intermolecular coupling reactions at different positions of cyclol‐Tyr‐l‐Tyr to generate novel tyrosine‐based alkaloids.

graphic file with name ANIE-61-0-g005.jpg

Introduction

2,5‐Diketopiperazines (DKPs) and their derivatives are widespread in nature and represent an important class of secondary metabolites.[ 1 , 2 ] They display a broad spectrum of biological and pharmacological activities, such as antibacterial, antifungal, antitumor, anti‐plasmodial, and anti‐Alzheimer properties.[ 3 , 4 , 5 , 6 , 7 , 8 ] Apart from these effects, they are also involved in quorum sensing and might be used in future as drug delivery systems due to a high cell penetration.[ 9 , 10 , 11 ] All these features make them attractive molecules for drug discovery and development. In nature, the heterocyclic DKP core of cyclodipeptides (CDPs) is usually formed by condensation of two α‐amino acids in two manners. This reaction is either catalyzed by nonribosomal peptide synthetases (NRPSs), mainly found in fungi, or by cyclodipeptide synthases (CDPSs), commonly occurring in bacteria.[ 12 , 13 , 14 ] In comparison to NRPSs, CDPSs are small proteins of approximate 30 kDa and use activated aminoacyl‐tRNAs from the ribosomal machinery as substrates. [15] The formation of a DKP as backbone exhibits an increased stability against proteolysis compared to acyclic dipeptides, which enables tailoring enzymes to modify the heterocycle or the side chains. [16] In the CDPS‐dependent pathways, such enzymes include cytochrome P450 enzymes, cyclodipeptide oxidases, FeII/2‐oxoglutarate‐dependent oxygenases, prenyltransferases, methyltransferases, and terpene cyclases.[ 17 , 18 , 19 , 20 , 21 , 22 ]

Members of the P450 enzyme superfamily occur ubiquitously in living organisms and play vital roles in the metabolism of xenobiotics as well as the biosynthesis of natural products.[ 23 , 24 , 25 ] Due to different lengths of the polypeptide chains, shapes of the binding pockets, and electron transfer partners, they can catalyze a large variety of transformations. [25] The catalytic activities of P450 enzymes in CDPS‐associated pathways include hydroxylation, e.g. BcmD in the formation of bicyclomycin,[ 18 , 26 ] multistep oxidation as CypX in the biosynthesis of pulcherriminic acid, [27] dimerization in the production of naseazine C and tetratryptomycins,[ 28 , 29 , 30 ] the formation of an intramolecular C−C bond by CYP121 in the mycocyclosin biosynthesis, [31] and transfer of nucleobases, e.g. guanine and hypoxanthine in the biosynthesis of guanitrypmycins, purincyclamide, and guatrypmethines (Figure 1A).[ 32 , 33 , 34 ]

Figure 1.

Figure 1

Known (A) and new (B) secondary metabolites from biosynthetic pathways containing CDPS and P450 enzymes. P450 enzymes catalyze novel CDP modifications including hydroxylation/oxidation (depicted in blue), formation of the intramolecular C−C bond in mycocyclosin and the nucleobase transfer reactions in guanitrypmycins and guatrypmethines (depicted in red).

Bioinformatic analysis revealed the presence of a widely distributed family of two‐gene clusters from Streptomyces species, termed gym clusters, each coding for a CDPS GymA and a P450 enzyme GymB. Herein, we report the identification of six of these clusters by heterologous expression in E. coli and Streptomyces albus (S. albus) as well as by biochemical characterization. Our results demonstrated that GymA1–GymA6 assemble cyclol‐Tyr‐l‐Tyr (cYY, 1) as main and cyclol‐Tyr‐l‐Phe (cYF, 2) as side product. The P450 enzymes GymB1–GymB6 catalyze the formation of mycocyclosin (3) by oxidative intramolecular C−C coupling and the transfer of a nucleobase, guanine or hypoxanthine, onto different positions of 1 for the formation of guatyromycines A (4) and B (5, Figure 1B), respectively. Thus, GymBs represent the first P450 members in CDPS‐related pathways that can catalyze both intra‐ and intermolecular coupling reactions.

Results and Discussion

In recent years, the number of microbial genomic sequences in the public databases, especially those of bacteria and fungi, has increased exponentially. [35] The available sequence data made us aware that the number and diversity of metabolites from a candidate organism is far greater than those reported. Among the tremendous number of putative gene clusters containing cdps genes, only a dozen CDPS‐related biosynthetic pathways have been characterized yet, implying that a great potential still remains unexplored.[ 15 , 17 , 19 ] In order to identify more cdpsP450‐containing gene clusters, we used the sequences of the functionally characterized CDPSs as probes to search for their homologs by using BLAST® and analyzed their neighboring genes coding for tailoring enzymes, especially for P450 enzymes. Phylogenetic analysis of known and putative CDPS and associated P450 sequences indicated the presence of a large group of unknown cdps‐P450 gene clusters (Figures S1 and S2). Phylogenetic analysis also revealed that the reported P450 enzymes responsible for nucleobase transfer and CDP dimerization are clustered in two distinct clades (Figure S2). It is noteworthy that CYP121, which catalyzes the intramolecular oxidative C−C coupling of cyclol‐Tyr‐l‐Tyr, [31] is located closest to the largest clade containing 47 unknown P450 homologs. Thus, we selected one representative from each of the subclades, in total six different cdps‐P450 gene clusters, for detailed investigation. These clusters were identified in Streptomyces flavidovirens DSM 40150 (gymA1B1 ), Streptomyces indicus DSM 42001 (gymA2B2 ), Streptomyces sp. NRRL S‐646 (gymA3B3 ), Streptomyces aureus NRRL B‐2808 (gymA4B4 ), Streptomyces katrae NRRL ISP‐5550 (gymA5B5 ), and Streptomyces sp. NRRL B‐3648 (gymA6B6 ) (Figure 2, Table S2). These candidate P450s share approximately 60 % sequence identities with CYP121 encoded by rv2276 on the amino acid level (Table S1).

Figure 2.

Figure 2

Genetic organization of the gym clusters from six Streptomyces strains.

Alignments of the six CDPSs from the selected clusters with AlbC from Streptomyces noursei (Figure S3) [36] and prediction of their substrate specificities[ 14 , 37 ] revealed that both binding pockets are specific for l‐Tyr‐tRNA, so that cyclol‐Tyr‐l‐Tyr can be expected as their product (Table S3). To investigate the cdps function, the coding sequences of gymA1–gymA6 were cloned into pET28a(+) for heterologous expression in E. coli BL21(DE3) (Tables S2 and S4). LC‐MS analysis of the bacterial cultures bearing the gymA genes revealed similar metabolite profiles and the presence of one predominant product with a [M+H]+ ion at m/z 327.134±0.005 and a minor peak with a [M+H]+ ion at m/z 311.139±0.005 (Figure S4). Comparison of the retention times, MS2 data, UV‐spectra (Figure S5), and NMR data (Table S6, Figures S8 and S9) with authentic standards led to the identification of predicted cyclol‐Tyr‐l‐Tyr (cYY, 1) as the main product (Table S3) and cyclol‐Tyr‐l‐Phe (cYF, 2) as the minor one. Production of two CDPs by one CDPS is in agreement with the published substrate promiscuity of other characterized enzymes.[ 38 , 39 ]

Heterologous expression of microbial biosynthetic gene clusters in well‐investigated host strains has proven to be an effective approach to discover new natural products. [40] Having determined the function of the backbone enzymes GymA1–GymA6 as cYY and cYF synthases, we decided to heterologously express the two‐gene clusters in S. albus J1074 to identify the cluster products. [41] Since GymB6 was located closest to CYP121 in the phylogenetic tree (Figure S2), the gymA6B6 cluster from Streptomyces sp. NRRL B‐3648 was taken as the first candidate. We first reproduced the expression of gymA6 in J1074 under control of the constitutive ermEp* promotor by using the replicative vector pPWW50A. [42] The transformant was cultivated in MR5 media (Table S2) and extracted with EtOAc. LC‐MS analysis revealed that, in comparison to the negative control with pPWW50A (Figure 3i), the gymA6 transformant produced both 1 and 2 as CDPS products (Figure 3ii), corresponding very well to those identified by expression in E. coli (Figure S4).

Figure 3.

Figure 3

HPLC analysis of the extracts from S. albus transformants. The dominant peak at 13 min in the negative control was strongly reduced in the transformants, as observed in other expression studies.[ 22 , 34 ] Therefore, it is unlikely related to the introduced gym genes.

The gymA6B6 cluster was then cloned into pPWW50A and expressed in S. albus. LC‐MS analysis of the cultural extract displayed three new peaks (Figure 3viii) with distinct UV absorptions (Figure S5). Peak 3 has a [M+H]+ ion at m/z 325.1180, corresponding well to that of mycocyclosin. [31] The [M+H]+ ion of 4 (m/z 476.1840) is 149 Da larger than that of 1, suggesting an additional guaninyl moiety on it. The [M+H]+ ion of 5 at m/z 461.1719 is 134 Da larger than that of 1, indicating the attachment of a hypoxanthinyl residue.

In order to elucidate the structures of the newly accumulated products, analytically pure compounds 35 were obtained by semi‐preparative HPLC and subjected to NMR analysis. Comparison of the 1H NMR spectrum with that published previously supported 3 to be mycocyclosin (see Figure 1A for structure, Table S6, Figure S10). [31] Detailed inspection of the NMR data of 4, including 1H, 13C, 1H–1H COSY, HSQC, and HMBC (Table S7, Figures S11–S15, see Supporting Information for detailed structure elucidation), suggested a cYY derivative with a guanine residue attached to a hydroxyl group (Figure 1B). Structure elucidation of 5 confirmed our assumption that a hypoxanthine is transferred via its C‐2′ to C‐10 of the cYY residue. (Table S8, Figures S16–S20). Cultivation of S. albus transformant harboring gymA6B6 in medium with 15NH4Cl and subsequent LC‐MS analysis of the cultural extract demonstrated that at least two 15N atoms are incorporated into in 3, seven in 4, and six in 5 (Figure S21), confirming the structures of 3, 4, and 5 (Figure 1). Based on the fact that 4 and 5 are derived from l‐tyrosine and guanine/hypoxanthine, they are therefore termed as guatyromycines A and B, respectively.

In analogy to gymA6B6 cluster from Streptomyces sp. NRRL B‐3648, we performed co‐expression of the genes for CDPS and P450 enzyme from the other five candidates (Figure 2) in S. albus. The plasmids (Table S4) were constructed as described in the Supporting Information and transferred into S. albus by conjugation. The extracts of the corresponding transformants were analyzed by LC‐MS (Figure 3), which revealed the presence of very similar product profiles as described for NRRL B‐3648. Together with their precursor 1 and the side product 2, all three products 3, 4, and 5 were clearly observed by UV and EIC detections (Figure 3iii–3vii, Figure S6). Their structures were further confirmed by comparison of their retention times, UV‐spectra, and MS data including MS2 fragmentation pattern with those of 3, 4, and 5 isolated in this study. As compound 3 is also the product of CYP121 from Mycobacterium tuberculosis, we decided to express the responsible cluster with two genes rv2275 and rv2276 as well. [31] In comparison, the cluster from M. tuberculosis mainly produced 3 with a product yield of 53.9±2.8 mg L−1 (Table S5), accompanied by 1 and 2 as minor peaks (Figure 3ix, Figure S6), confirming that CYP121 merely catalyzes the formation of 3. [31] Quantification of the productivity of the different transformants (Table S5) showed that 4 and 5 were accumulated in comparable product yields of 2.3–5.5 mg L−1, while the contents of 3 varied significantly from 1.6±0.2 mg L−1 for gymA2B 2 to 24.0±1.3 mg L−1 for gymA6B 6.

An intramolecular coupling product of cYF (2) or its adduct with hypoxanthine were detected neither by UV nor by [M+H]+ ion detection in all of the transformants described in this study (Figure S7). In contrast, a clear peak 6 at 17.8 min was detected with a m/z of 460.173±0.005, corresponding to the [M+H]+ ion of 2 with guanine, in the transformants carrying gymA1B1–gymA6B 6. However, this peak is so weak that it's almost not visible by UV detection (Figure 3). Due to the low quality, its structure could not be elucidated in this study.

From these results, it can be postulated that the CDPSs GymA1–GymA6 use tyrosyl‐tRNA and phenylalanyl‐tRNA as substrates to assemble cYY (1) as the major and cYF (2) as the minor product. cYY serves then as the substrate of the cytochrome P450 enzymes GymB1–GymB6 for intramolecular oxidative C−C bond formation and coupling with guanine and hypoxanthine via different atoms and positions of cYY, resulting in mycocyclosin (3), guatyromycines A (4) and B (5), respectively (Figure 1). It is likely that 2 was also used by GymB1–GymB6 as the substrate for coupling with guanine.

To prove the activities of GymB1–GymB6 in vitro, their coding sequences were cloned into pET28a(+) for overproduction in E. coli BL21(DE3) (Table S4). The recombinant His 6‐tagged GymB1–GymB6 were purified on Ni‐NTA agarose (Figure S22) and used for in vitro assays with 1, guanine, and hypoxanthine in the presence of ferredoxin, ferredoxin‐reductase, and NADPH. Heat‐inactivated proteins served as negative controls. After incubation at 30 °C for 16 h, the reactions were quenched with MeOH and analyzed by LC‐MS. As shown in Figure 4, 4 was detected in all the assays with active enzymes as the major product, followed by 5 and 3. These results confirmed unequivocally that GymB1–GymB6 catalyze both the nucleobase transfer reactions and the intramolecular C−C bond coupling. They act therefore as bifunctional enzymes. In the absence of guanine and hypoxanthine, GymB1–GymB6 converted 1 to 3 with much higher yields than with nucleobases (Figure S23). A peak “x” at 9.5 min was detected in EIC for 3 of some assays with and without nucleobases (Figures 4 and S23), indicating the presence of a mycocyclosin isomer. Due to the trace product amount, its structure could not be determined in this study.

Figure 4.

Figure 4

LC‐MS chromatograms of cYY assays with GymB1–GymB6 in the presence of guanine and hypoxanthine. EICs of 3, 4, and 5 refer to [M+H]+ ions at m/z 325.118, 476.184, 461.172 with a tolerance range of ±0.005. Peak x: unknown mycocyclosin isomer. inact.: heat‐inactivated; std.: standard.

It can be postulated that the abstraction of one hydrogen from OH at C‐11 by the FeIV=O species (compound I) leads to the formation of a radical at O‐21, which acts as a central intermediate for the formation of mycocyclosin (3) [43] and guatyromycines A (4) and B (5) (Figure 5). Transfer of a hydrogen from the second hydroxyl group to FeIV−OH (compound II) and release of one molecule H2O will result in the formation of a diradical intermediate. Electron migration to C‐10 and C‐17, radical combination and subsequent rearomatization will release product 3 from the GymBx template. Direct reaction of the radical at O‐21 with C‐8' of guanine, transfer of one hydrogen to FeIV−OH and water elimination lead to the formation of guatyromycine A (4). In the case of the formation of guatyromycine B (5), the radical at O‐21 would first undergo electron migration, resulting in a radical at C‐10, which couples with hypoxanthine at its C‐2′. Water elimination and rearomatization complete the formation of 5 (Figure 5). The FeIII species will be reduced to FeII by reduction partners ferredoxin/ferredoxin reductase/NADPH and is ready for binding of O2 for the next reaction cycle.[ 25 , 44 ] It seems that C‐2′ in hypoxanthine is preferred to react with C‐10 of cYY in analogy to the formation of mycocyclosin, which has been investigated in detail. [43] The connection of guanine with cYY is likely caused by the amino substitution at C‐2′ of the purine skeleton and a resulting steric hindrance in the binding pocket of the enzymes.

Figure 5.

Figure 5

Biosynthetic pathway of 3, 4, and 5 and mechanism of the GymB‐catalyzed reactions.

Conclusion

In this study, we demonstrated by heterologous expression the presence of a widely distributed family of two‐gene clusters coding for a CDPS and a cytochrome P450 enzyme in actinobacteria (Figures S1 and S2), which produce both mycocyclosin (3) by intramolecular oxidative C−C coupling of cYY (1) and guatyromycines A (4) and B (5) by transfer of a nucleobase onto different positions of 1. Biochemical investigations by using recombinant P450 enzymes GymB1–GymB6 proved the conversion of 1 to 3, 4, and 5. To the best of our knowledge, the GymBs are the first described CDPS‐associated P450s that function as unique bifunctional enzymes for both intramolecular coupling and nucleobase transfer onto a tyrosyl moiety, which is different from those reported previously.[ 31 , 32 , 34 , 45 , 46 ]

Cultivation of the six gymAB‐bearing Streptomyces species given in Figure 2 in two different media and LC‐MS analysis of the extracts did not lead to detection of any products mentioned above, indicating the presence of silent genes in the native strains (data not shown).

Mycocyclosin (3) has been proven to be the product of a gene cluster with a CDPS gene rv2275 and the gene rv2276 for the cytochrome P450 enzyme CYP121 from M. tuberculosis. [31] No adduct of 1 with nucleobases was reported. We confirmed in this study these results by heterologous expression of rv2275/rv2276 in S. albus. A product yield of 53.9 mg L−1 was achieved for 3. This is two‐ to twenty‐fold of the transformants carrying gym clusters (Table S5). It could be speculated that gymBs and their potential orthologues evolved from rv2276. Phylogenetic analysis revealed a coherence of the product yields for 3 in the respective transformants and their sequence proximity. For example, GymB4–6 are located closely to CYP121 and the S. albus transformants with their clusters produced 3 at 9.4–24.0 mg L−1, significantly higher than 1.6 mg L−1 in the gymA2B2 and 2.3 mg L−1 in the gymA1B1 transformant.

In summary, this study demonstrates again the power of the combinational approaches of genome mining in the available databases, heterologous expression in well‐established hosts and biochemical characterization with recombinant proteins for the discovery of new secondary metabolites and intriguing enzymes. It can be expected that more novel natural product structures and enzymes will be discovered in the future by unravelling the biosynthetic potential hidden behind the silent/cryptic genes in the tremendous available genome sequences.

Conflict of interest

The authors declare no conflict of interest.

1.

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supporting Information

Acknowledgements

We thank the ARS Culture Collection (NRRL) for providing Streptomyces strains, Rixa Kraut, Lena Ludwig‐Radtke, Dr. Regina Ortmann, and Stefan Newel (Marburg) for MS and NMR measurement. This project was funded in part by the Deutsche Forschungsgemeinschaft (DFG, INST 160/620‐1 and Li844/14‐1). Jing Liu (201608310118) and Yiling Yang (201808530447) are scholarship recipients from the China Scholarship Council. Open Access funding enabled and organized by Projekt DEAL.

J. Liu, L. Harken, Y. Yang, X. Xie, S.-M. Li, Angew. Chem. Int. Ed. 2022, 61, e202200377; Angew. Chem. 2022, 134, e202200377.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  • 1. Apostolopoulos V., Bojarska J., Chai T. T., Elnagdy S., Kaczmarek K., Matsoukas J., New R., Parang K., Lopez O. P., Parhiz H., Perera C. O., Pickholz M., Remko M., Saviano M., Skwarczynski M., Tang Y., Wolf W. M., Yoshiya T., Zabrocki J., Zielenkiewicz P., AlKhazindar M., Barriga V., Kelaidonis K., Sarasia E. M., Toth I., Molecules 2021, 26, 430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Song Z., Hou Y., Yang Q., Li X., Wu S., Mar. Drugs 2021, 19, 403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Musetti R., Polizzotto R., Vecchione A., Borselli S., Zulini L., D′Ambrosio M., di Toppi L. S., Pertot I., Micron. 2007, 38, 643–650. [DOI] [PubMed] [Google Scholar]
  • 4. Buedenbender L., Grkovic T., Duffy S., Kurtböke D. I., Avery V. M., Carroll A. R., Tetrahedron Lett. 2016, 57, 5893–5895. [Google Scholar]
  • 5. Kohn H., Widger W., Curr. Drug Targets Infect. Disord. 2005, 5, 273–295. [DOI] [PubMed] [Google Scholar]
  • 6. Turkez H., Cacciatore I., Arslan M. E., Fornasari E., Marinelli L., Di S. A., Mardinoglu A., Biomolecules 2020, 10, 737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Ström K., Sjögren J., Broberg A., Schnürer J., Appl. Environ. Microbiol. 2002, 68, 4322–4327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Ding Z., Li F., Zhong C., Li F., Liu Y., Wang S., Zhao J., Li W., Bioorg. Med. Chem. 2020, 28, 115435. [DOI] [PubMed] [Google Scholar]
  • 9. Sun S. J., Liu Y. C., Weng C. H., Sun S. W., Li F., Li H., Zhu H., Biomolecules 2020, 10, 298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Zhu J., Zhang Y., Deng J., Jiang H., Zhuang L., Ye W., Ma J., Jiang J., Feng L., J. Agric. Food Chem. 2019, 67, 12013–12025. [DOI] [PubMed] [Google Scholar]
  • 11. Feni L., Jutten L., Parente S., Piarulli U., Neundorf I., Diaz D., Chem. Commun. 2020, 56, 5685–5688. [DOI] [PubMed] [Google Scholar]
  • 12. Izoré T., Cryle M. J., Nat. Prod. Rep. 2018, 35, 1120–1139. [DOI] [PubMed] [Google Scholar]
  • 13. Payne J. A., Schoppet M., Hansen M. H., Cryle M. J., Mol. BioSyst. 2017, 13, 9–22. [DOI] [PubMed] [Google Scholar]
  • 14. Gondry M., Jacques I. B., Thai R., Babin M., Canu N., Seguin J., Belin P., Pernodet J. L., Moutiez M., Front. Microbiol. 2018, 9, 46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Canu N., Moutiez M., Belin P., Gondry M., Nat. Prod. Rep. 2020, 37, 312–321. [DOI] [PubMed] [Google Scholar]
  • 16. Borthwick A. D., Chem. Rev. 2012, 112, 3641–3716. [DOI] [PubMed] [Google Scholar]
  • 17. Harken L., Li S.-M., Appl. Microbiol. Biotechnol. 2021, 105, 2277–2285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Meng S., Han W., Zhao J., Jian X. H., Pan H. X., Tang G. L., Angew. Chem. Int. Ed. 2018, 57, 719–723; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 727–731. [Google Scholar]
  • 19. Borgman P., Lopez R. D., Lane A. L., Org. Biomol. Chem. 2019, 17, 2305–2314. [DOI] [PubMed] [Google Scholar]
  • 20. Zhang Y., Yao T., Jiang Y., Li H., Yuan W., Li W., Appl. Environ. Microbiol. 2021, 87, e02525-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Yao T., Liu J., Liu Z., Li T., Li H., Che Q., Zhu T., Li D., Gu Q., Li W., Nat. Commun. 2018, 9, 4091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Liu J., Yang Y., Harken L., Li S.-M., J. Nat. Prod. 2021, 84, 3100–3109. [DOI] [PubMed] [Google Scholar]
  • 23. Nelson D. R., Biochim. Biophys. Acta Proteins Proteomics 2018, 1866, 141–154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Dunham N. P., Arnold F. H., ACS Catal. 2020, 10, 12239–12255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Chen C.-C., Min J., Zhang L., Yang Y., Yu X., Guo R.-T., ChemBioChem 2021, 22, 1317–1328. [DOI] [PubMed] [Google Scholar]
  • 26. Patteson J. B., Cai W., Johnson R. A., Santa Maria K. C., Li B., Biochemistry 2018, 57, 61–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Cryle M. J., Bell S. G., Schlichting I., Biochemistry 2010, 49, 7282–7296. [DOI] [PubMed] [Google Scholar]
  • 28. Shende V. V., Khatri Y., Newmister S. A., Sanders J. N., Lindovska P., Yu F., Doyon T. J., Kim J., Houk K. N., Movassaghi M., Sherman D. H., J. Am. Chem. Soc. 2020, 142, 17413–17424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Sun C., Peng H., Zhang W., Zheng M., Tian W., Zhang Y., Liu H., Lin Z., Deng Z., Qu X., J. Org. Chem. 2021, 86, 11189–11197. [DOI] [PubMed] [Google Scholar]
  • 30. Liu J., Xie X., Li S.-M., Chem. Commun. 2020, 56, 11042–11045. [DOI] [PubMed] [Google Scholar]
  • 31. Belin P., Le Du M. H., Fielding A., Lequin O., Jacquet M., Charbonnier J. B., Lecoq A., Thai R., Courcon M., Masson C., Dugave C., Genet R., Pernodet J. L., Gondry M., Proc. Natl. Acad. Sci. USA 2009, 106, 7426–7431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Yu H., Xie X., Li S.-M., Org. Lett. 2019, 21, 9104–9108. [DOI] [PubMed] [Google Scholar]
  • 33. Shi J., Xu X., Zhao E. J., Zhang B., Li W., Zhao Y., Jiao R. H., Tan R. X., Ge H. M., Org. Lett. 2019, 21, 6825–6829. [DOI] [PubMed] [Google Scholar]
  • 34. Harken L., Liu J., Kreuz O., Berger R., Li S.-M., ACS Catal. 2022, 12, 648–654. [Google Scholar]
  • 35. Scherlach K., Hertweck C., Nat. Commun. 2021, 12, 3864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Lautru S., Gondry M., Genet R., Pernodet J. L., Chem. Biol. 2002, 9, 1355–1364. [DOI] [PubMed] [Google Scholar]
  • 37. Jacques I. B., Moutiez M., Witwinowski J., Darbon E., Martel C., Seguin J., Favry E., Thai R., Lecoq A., Dubois S., Pernodet J. L., Gondry M., Belin P., Nat. Chem. Biol. 2015, 11, 721–727. [DOI] [PubMed] [Google Scholar]
  • 38. Liu J., Yu H., Li S.-M., Appl. Microbiol. Biotechnol. 2018, 102, 4435–4444. [DOI] [PubMed] [Google Scholar]
  • 39. Giessen T. W., von Tesmar A. M., Marahiel M. A., Biochemistry 2013, 52, 4274–4283. [DOI] [PubMed] [Google Scholar]
  • 40. Medema M. H., de R. T., Moore B. S., Nat. Rev. Genet. 2021, 22, 553–571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Zaburannyi N., Rabyk M., Ostash B., Fedorenko V., Luzhetskyy A., BMC Genomics 2014, 15, 97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Zhu Y., Fu P., Lin Q., Zhang G., Zhang H., Li S., Ju J., Zhu W., Zhang C., Org. Lett. 2012, 14, 2666–2669. [DOI] [PubMed] [Google Scholar]
  • 43. Dumas V. G., Defelipe L. A., Petruk A. A., Turjanski A. G., Marti M. A., Proteins Struct. Funct. Bioinf. 2014, 82, 1004–1021. [DOI] [PubMed] [Google Scholar]
  • 44. Greule A., Stok J. E., De Voss J. J., Cryle M. J., Nat. Prod. Rep. 2018, 35, 757–791. [DOI] [PubMed] [Google Scholar]
  • 45. Liu J., Xie X., Li S.-M., Angew. Chem. Int. Ed. 2019, 58, 11534–11540; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2019, 131, 11658–11664. [Google Scholar]
  • 46. Yu H., Xie X., Li S.-M., Org. Lett. 2018, 20, 4921–4925. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supporting Information

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Angewandte Chemie (International Ed. in English) are provided here courtesy of Wiley

RESOURCES